La Madonnina Clinic
La Madonnina Clinic
Italy, Milan
Crohn's disease treatment cost in Italy typically includes diagnostics like colonoscopy with biopsy which runs from $700 to $1,100. Advanced treatment options such as stem cell therapy range from $10,000 to $18,000. Total expenses depend on disease activity, required biologics, and hospital stay duration. Patients can find approximately 30-50% savings compared to the US. Top cities for gastroenterology include Milan, Rome, and Turin.
Typical Crohn's Disease Treatment Costs in Italy
Bookimed Expert Insight: Patients seeking high-end medical care find the San Donato Network clinics in Milan ideal. La Madonnina Clinic caters to high-profile patients with premium service and experienced specialists. For those prioritizing innovation, Mater Olbia Hospital in Rome serves as an international center of excellence. These facilities offer cutting-edge technology for complex gastrointestinal cases requiring multidisciplinary expertise.
| Italy | Turkey | Austria | |
| Stem Cell Therapy | from $10,000 | from $7,200 | from $8,500 |
| Resection of gallbladder | from $7,000 | from $2,900 | from $9,000 |
| Hormone therapy | from $2,500 | from $401 | from $7,000 |
| Selective Apheresis | from $3,100 | from $1,550 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Crohn's disease treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Crohn's disease treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Crohn's disease treatment journey.
Dr. Milutin Bulajic directs the Gastroenterology and Digestive Endoscopy Department at Mater Olbia Hospital. He specializes in therapeutic endoscopy and gastrointestinal oncology. Dr. Bulajic earned his PhD from the University of Belgrade. He focuses on innovative treatments for pancreatic diseases and colorectal cancer screening.
The doctor is a specialist in Gastroenterology and Bariatric Surgery at the Madonnina Clinic in Milan, Italy. With a clinical focus on conditions such as Gastritis, Ascites, Obesity, Stomach Ulcer, and Colon Cancer, the doctor is dedicated to providing expert care in these areas.
Advanced Crohn's disease treatments in Italy include IL-23 inhibitors like Risankizumab and oral JAK inhibitors such as Upadacitinib. Specialized centers offer stem cell therapy for refractory cases. Leading facilities in Milan and Rome provide biologic therapies, clinical trials, and gut-selective integrin inhibitors for targeted inflammation control.
Bookimed Expert Insight: While many search for the newest drugs, the real advantage in Italy is the integration of research hubs. Mater Olbia Hospital in Rome combines expertise from the Qatar Foundation and Fondazione Policlinico Gemelli. This partnership allows patients to access clinical trials for advanced combination treatments (ACT). These protocols use multiple biologics simultaneously for cases that do not respond to standard care.
Patient Consensus: Patients note that seeking private consultations can significantly shorten wait times for high-demand biologics like Ustekinumab. Many suggest preparing detailed flare history and medical records to fast-track approvals within specialized regional networks.
Italy hosts leading centers for Crohns disease specializing in biological therapies and advanced diagnostics. Humanitas Research Hospital and Agostino Gemelli University Policlinic serve as primary referral hubs. These facilities utilize multidisciplinary teams including specialized surgeons and gastroenterologists to manage complex inflammatory bowel conditions.
Bookimed Expert Insight: Patients seeking premium care often choose La Madonnina Clinic in Milan. It is part of the San Donato Network and treats high-profile individuals. While it is a private facility, its link to major research networks ensures access to top experts. This presents a faster alternative to public university hospitals where wait times are often significant.
Patient Consensus: Patients often recommend choosing university-affiliated hospitals over general facilities for better specialty care. Many note that northern Italian hospitals typically offer more updated medical protocols than southern regions.
Italy supports Crohn's disease care through the Servizio Sanitario Nazionale (SSN). It classifies the condition as a chronic illness. This status grants patients a ticket exemption for diagnostic tests and specialist visits. The system fully subsidizes biological therapies and surgical procedures in public hospitals.
Bookimed Expert Insight: Patients can navigate regional wait times by using Italy's cross-regional referral system. If a local facility is overbooked, the SSN may authorize and fund treatment in other regions. This is especially useful for complex surgeries at high-volume centers like Mater Olbia Hospital. Utilizing this legislative right ensures timely access to specialized gastroenterology teams without incurring private surgical fees.
Patient Consensus: Patients note that registering with a regional IBD hub provides a dedicated coordinator. This significantly simplifies scheduling appointments and obtaining prescriptions compared to managing standard public referrals alone.
Specialists in Italy treat Crohn's disease using guidelines from the European Crohn's and Colitis Organisation (ECCO). They follow a step-up approach, starting with aminosalicylates or steroids. Biological therapies, such as IL-12/23 inhibitors and JAK inhibitors, are standard for moderate-to-severe cases.
Bookimed Expert Insight: Italian gastrointestinal care is dominated by large medical networks like the San Donato Group. This helps clinical teams quickly coordinate with surgeons if medication stops working. Patients often find better continuity in Milan-based clinics with large multidisciplinary GI departments.
Patient Consensus: Patients note that care is led by specialist gastroenterologists rather than GPs. Most recommend discussing biologic therapy early if conventional drugs fail to manage flare-ups.
Leading Italian centres for Crohn's disease treatment include Mater Olbia Hospital in Rome and La Madonnina Clinic in Milan. These facilities specialise in multidisciplinary care. They offer biological therapies and diagnostic techniques like capsule endoscopy. Experts focus on managing chronic intestinal inflammation using research-based protocols.
Bookimed Expert Insight: Italian healthcare excellence often stems from IRCCS status. This designates a facility as a Scientific Institute for Research and Healthcare. Mater Olbia Hospital integrates the research-heavy model used by Agostino Gemelli. Patients benefit from 22 specialised departments and 113 doctors who apply academic findings to clinical practice.
Patient Consensus: Patients find that coordinating with a local GP in Italy helps secure hospital referrals. It is important to confirm clinical trial suitability with home teams before seeking biological care.
Australian medical tourists can access private Crohn’s disease treatment in Italy by paying directly for specialist services. A reciprocal agreement exists but only covers public emergency care. Private facilities provide elective diagnostics like capsule endoscopy and colonoscopies without long public wait times.
Bookimed Expert Insight: Italian private healthcare revolves around large medical groups like the San Donato Network. Choosing a clinic like La Madonnina ensures access to shared specialist resources. This network structure often provides more consistent billing and administrative support for international patients.
Patient Consensus: Patients note it is essential to bring complete pathology and biologic medication histories. Confirming infusion schedules and English-speaking support in advance helps manage potential flares while in Italy.